MTOR and nasopharyngeal carcinoma: Moreover, the results of the IHC analysis of xenografts confirmed the role of IGF2BP3 in inducing the EMT process through AKT signalling, indicating that IGF2BP3 functions as an oncogene in NPC cells by activating the AKT/mTOR signalling pathway.